Introduction

Knee pain from joint wear is common and can affect everyday activities. Many people would prefer a non-surgical option before considering more involved procedures. This article looks at the ChondroFiller injection — a non-surgical, ultrasound-guided collagen injection for the knee — with realistic expectations throughout.

Understanding Knee Joint Wear

Cartilage cushions the bones in the knee and distributes load across the joint. It can be worn down by injury, everyday use or ageing, and because articular cartilage has a limited capacity to repair itself, this wear can cause persistent pain and stiffness.

How the ChondroFiller Injection Works

ChondroFiller is a CE-marked Class III type I collagen hydrogel scaffold, manufactured by Meidrix Biomedicals in Germany and imported into the UK under prescription. As an injection, it is given as a non-surgical, ultrasound-guided outpatient procedure directly into the knee joint. Once inside, the gel self-sets in approximately three to five minutes and may settle over worn surfaces, adding a protective collagen layer that helps cushion the joint and reduce grinding. The scaffold is acellular — it contains no donor cells — and works by recruiting the patient's own progenitor cells to support the joint environment. It can absorb load and adapt to the forces inside the joint. ChondroFiller is best understood as a supportive, joint-preserving injection and not a guaranteed repair, cure, or reversal of arthritis.

ChondroFiller is a distinct product from the Liquid Cartilage surgical protocol. Liquid Cartilage is a keyhole (arthroscopic) surgical technique developed by Professor Paul Y. F. Lee that delivers the ChondroFiller scaffold together with biological adjuncts and, where indicated, the patient's own mesenchymal stem cells. That procedure requires theatre and anaesthetic and is suited to larger or more complex defects. The injection discussed in this article is the non-surgical, outpatient delivery route — appropriate for accessible lesions where the clinical picture does not require surgery.

Practical Benefits

Because ChondroFiller is given as an outpatient injection rather than an operation, most people return to normal activities promptly. There is no incision and no general anaesthetic. It may suit people with knee osteoarthritis or joint wear who want a non-surgical option, though suitability depends on the extent of wear, the joint involved, and overall health. Benefits cannot be guaranteed, and individual assessment by a qualified clinician is essential.

ChondroFiller and Hyaluronic Acid Injections

Hyaluronic acid injections ease symptoms primarily by lubricating the joint surface. ChondroFiller is a collagen-based injection that may add a protective, cushioning layer over worn surfaces and has biological potential through its recruitment of progenitor cells. The two work by different mechanisms and can suit different clinical situations; a specialist can advise which, if either, may be appropriate for a given patient.

Conclusion

ChondroFiller is a non-surgical collagen injection that may help support a worn knee and ease symptoms for some people, with a prompt return to activity. If you experience knee pain from joint wear, an assessment with a qualified clinician is the right starting point for realistic, individual advice. At the London Cartilage Clinic, Harley Street, consultations are available to determine whether the ChondroFiller injection or another approach may be appropriate for your knee.

References

Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.